The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
News|Articles|June 9, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 9, 2022
Author(s)Sydney Jennings
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the Centers for Disease Control and Prevention (CDC) as of today, June 9, 2022, at 2:37 PM, EDT:
47% of fully vaccinated persons in the US have received a booster dose of COVID-19 vaccine.
What percentage of people across age groups in the US have been fully vaccinated?
• 66.7% of total US population
• 70.9% of US population aged ≥5 years
• 75.2% of US population aged ≥12 years
• 76.7% of US population aged ≥18 years
• 91.2% of US population aged ≥65 years
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, June 9, 2022 at 1:20 PM, EDT, there have been:
• 85 260 806 confirmed cases and
• 1 010 608 deaths
• 1 010 608 deaths
In the past 28 days, the 3 states with the most new cases are:
1. California: 405 088
2. Florida: 245 074
3. New York: 228 889
2. Florida: 245 074
3. New York: 228 889
Deaths: California has the highest number of deaths due to COVID-19 with 91 595 reported fatalities, followed by Texas with 88 421 and Florida with 74 766.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 533 878 807 confirmed cases, 6 305 684 deaths, and 11 530 130 935 vaccine doses administered.
Advertisement
Related to this article
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank study of dietary patterns.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart failure monitoring.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
Advertisement
Advertisement